|
|
Volumn 334, Issue 5, 2001, Pages 143-147
|
|
Antifungal actinomycete metabolites discovered in a differential cell-based screening using a recombinant TOPO1 deletion mutant strain
|
|
Author keywords
Actinomycetes; Antifungal activity; Collismycin; Natural products screening; Nonactic acid
|
|
Indexed keywords
ANTIFUNGAL AGENT;
COLLISMYCIN A;
COLLISMYCIN B;
CYCLOHOMONONACTIC ACID;
CYCLONONACTIC ACID;
NATURAL PRODUCT;
UNCLASSIFIED DRUG;
ACTINOBACTERIA;
ANALYTIC METHOD;
ANTIFUNGAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DELETION MUTANT;
DRUG ISOLATION;
DRUG STRUCTURE;
ENZYME ASSAY;
GENETIC RECOMBINATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
SCREENING TEST;
STRAIN DIFFERENCE;
2,2'-DIPYRIDYL;
ACTINOMYCETALES;
ANTIFUNGAL AGENTS;
CARBOXYLIC ACIDS;
DNA TOPOISOMERASES, TYPE I;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR CONFORMATION;
MOLECULAR STRUCTURE;
STEREOISOMERISM;
|
|
EID: 0034995883
PISSN: 03656233
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-4184(200105)334:5<143::AID-ARDP143>3.0.CO;2-B Document Type: Article |
|
Times cited : (22)
|
|
References (14)
|
